Revista española de anestesiología y reanimación
-
Rev Esp Anestesiol Reanim · Nov 1999
[Scientific publications from the Spanish anesthesiology departments in 1989-1998. Authorship of the articles].
To quantify the scientific publication of Spanish anesthesiologists and analyse article authorship. ⋯ The bibliographic indices that reflect publication by Spanish anesthesiologists internationally is evolving positively. Data from Spanish journals allow us to deduce the existence of a certain degree of unjustified addition of authors. A quantitative-qualitative method for rating curriculum vitae is proposed in order to reduce that tendency.
-
Rev Esp Anestesiol Reanim · Nov 1999
[Impact of Spanish publications on foreign anesthesiology journals].
To analyze the number of articles by Spanish authors in three international anesthesiology journals and assess the impact of Spanish anesthesiology literature during the same period by way of citations. ⋯ The number of Spanish articles published in Anesthesiology, BJA, and Anesth Analg is low, although the comparison of our productivity with that of other EU countries in function of GNPpc places us in an intermediate position. The impact of Spanish literature on international studies is low, particularly research published in Spanish national journals, a circumstance that is reflected even in articles published by Spanish authors.
-
Rev Esp Anestesiol Reanim · Nov 1999
Review[Esmolol in anesthesiology: pharmacology and indications].
Esmolol is a beta-adrenergic receptor antagonist with a relatively specific affinity for beta 1 adrenergic receptors. Its mechanism of action is therefore largely cardioselective and only high doses block beta 2 adrenergic receptors. The pharmacologic features of the drug give it rapid onset of beta-blocking action (distribution half-life = 2 minutes) and a short duration of action due to rapid clearance (clearance half-life = 9 minutes). ⋯ The esmolol dose is therefore manageable and individual adjustments can be made in function of a patient's clinical status. Such properties mean that esmolol is indicated for short-term treatment of hypertension and tachycardia during the perioperative period and in clinical situations that require easy unblocking of beta receptors. Hypertension and bradycardia are the most frequent complications associated with the administration of esmolol, such that blood pressure, heart rate and electrocardiographic data must be monitored.
-
Rev Esp Anestesiol Reanim · Nov 1999
Clinical Trial[Electroencephalographic and hemodynamic monitoring at various desflurane concentrations].
To assess the electroencephalographic patterns and hemodynamic changes produced by desflurane at 0.5, 1 and 1.5 MAC. ⋯ Automated EEG processing can provide a good measure of depth of anesthesia, as it reflects significant changes related to level of anesthesia at each phase. These differences are not always observable with routine monitoring of hemodynamic parameters.